Clear Cell Carcinoma clinical trials at UCSD

1 in progress, 0 open to eligible people

XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies
Sorry, in progress, not accepting new patients
This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of vudalimab (XmAb20717) in patients with selected advanced gynecologic and genitourinary malignancies.
La Jolla 5363943, California 5332921 and other locations

Last updated: February 2025